sumanta k. pal, md, regarding the quality of life outcomes from checkmate 9er
Published 3 years ago • 59 plays • Length 1:25
Download video MP4
Download video MP3
Similar videos
-
1:18
sumanta k. pal, md, elaborates on the design and outcomes of the papmet trial from asco gu 2021
-
1:19
sumanta k. pal, md, elaborates on the significance of the clear trial from asco gu 2021
-
1:45
sumanta k. pal, md, offers opinion on the treatment of clear cell renal cell carcinoma
-
3:49
cabozantinib benefit for metastatic papillary rcc demonstrated | sumanta pal
-
5:58
checkmate 9er update confirms benefits of nivolumab–cabozantinib in rcc | cristina suárez
-
2:04
sumanta k. pal, md, shares thoughts on the tivo-3 trial from asco gu 2021
-
0:55
sumanta k. pal, md, considers the unmet needs in the treatment of papillary rcc
-
9:38
pathology insights: challenging cutaneous spindle cell tumors with steven billings, md
-
22:04
data interpretation in conn's investigation 4th may 2000 masterclass
-
6:00
mantle cell lymphoma: improved prognosis
-
3:35
checkmate-9er discussion: depth of response with first-line cabozantinib/nivolumab
-
4:00
sumanta k. pal, md
-
0:59
sumanta kumar pal, md, discusses his recently published work and how it has impacted approach to rcc
-
3:14
#kcrs19: sumanta pal, m.d.
-
0:52
sumanta kumar pal, md, regarding hif-2 being the next target for novel precision cancer medicine
-
1:12
cristina suárez, md, elaborates on the outcomes of the checkmate 9er study presented at esmo 2020
-
5:21
jorge a. garcia, md, summarizes the significance of checkmate 9er from asco gu 2021
-
1:38
hope talks | meet sumanta pal, m.d.
-
1:32
dr. pal compares checkmate-214 and cabosun trials in rcc
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
1:45
sumanta pal on new treatments and tinivo-2 for rcc
-
1:33
dr. pal on the checkmate-214 and cabosun studies in rcc
Clip.africa.com - Privacy-policy